by Sabine Possmann | Jun 24, 2019 | Uncategorized
In close collarboration between the CARAMBA partners Paul-Ehrlich-Insitiute, DRK-BSD and the University Hospital in Wuerzburg, first CARAMBA data were published on the bioRxiv platform. Genomic Analyses of SLAMF7 CAR-T Cells Manufactured by Sleeping Beauty Transposon...
by Sabine Possmann | May 6, 2019 | Uncategorized
With the aim of providing an overview of CAR-T cell treatment in myeloma, healthcare professional expectations and an introduction to some of the advantages and challenges for patients and in bringing it to market, Myeloma Patients Europe (MPE) will held a webinar on...
by Sabine Possmann | May 2, 2019 | Uncategorized
Myeloma Patients Europe held its annual General Assembly on 15-17 March 2019 in Munich, Germany. Next to training, scientific and advocacy sessions, CARAMBA coordinator Dr. Michael Hudecek presented on CAR-T cells in multiple myeloma and AL amyloidosis. Watch here the...
by Sabine Possmann | Apr 3, 2019 | Uncategorized
On 1st and 2nd April 2019, the CARAMBA General Assembly met for the second time in Wuerzburg to discuss recent results and the next steps towards the clinical trial. All partners enjoyed the friendly and dynamic working atmosphere allowing fruitful discussions and...
by Sabine Possmann | Apr 1, 2019 | Uncategorized
Download the CARAMBA_Flyer and share it with your networks!
by Sabine Possmann | Mar 19, 2019 | Uncategorized
CARAMBA at the 1st European CAR-T workshop The 1st European CAR-T workshop (14-16 February 2019, Paris) jointly organized by EHA and the EBMT, was co-chaired by the CARAMBA coordinator Dr. Michael Hudecek (Universitaetsklinikum Wuerzburg). Next to the coordinator Dr....
